Publication | Closed Access

Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

Hematological MalignancyMolecular PharmacologyAntimetabolite PharmacologyMedicineMixed-phenotype Acute LeukemiaHematologyPharmacologyMyeloid NeoplasiaPharmacotherapyAnti-cancer AgentOncologyRadiation OncologyHealth Sciences